ATE511509T1 - Azaindolylverbindungen und anwendungsverfahren - Google Patents
Azaindolylverbindungen und anwendungsverfahrenInfo
- Publication number
- ATE511509T1 ATE511509T1 AT07854844T AT07854844T ATE511509T1 AT E511509 T1 ATE511509 T1 AT E511509T1 AT 07854844 T AT07854844 T AT 07854844T AT 07854844 T AT07854844 T AT 07854844T AT E511509 T1 ATE511509 T1 AT E511509T1
- Authority
- AT
- Austria
- Prior art keywords
- methods
- application
- azaindolyl
- compounds
- azaindolyl compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86805506P | 2006-11-30 | 2006-11-30 | |
| US91762007P | 2007-05-11 | 2007-05-11 | |
| US94474307P | 2007-06-18 | 2007-06-18 | |
| PCT/US2007/085962 WO2008067481A1 (en) | 2006-11-30 | 2007-11-29 | Aza-indolyl compounds and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE511509T1 true ATE511509T1 (de) | 2011-06-15 |
Family
ID=39169665
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07854844T ATE511509T1 (de) | 2006-11-30 | 2007-11-29 | Azaindolylverbindungen und anwendungsverfahren |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7855216B2 (de) |
| EP (1) | EP2099796B1 (de) |
| JP (1) | JP5211063B2 (de) |
| AR (1) | AR064031A1 (de) |
| AT (1) | ATE511509T1 (de) |
| AU (1) | AU2007325123B2 (de) |
| CA (1) | CA2672327A1 (de) |
| CL (1) | CL2007003444A1 (de) |
| DK (1) | DK2099796T3 (de) |
| HK (1) | HK1135099A1 (de) |
| PE (1) | PE20081354A1 (de) |
| PL (1) | PL2099796T3 (de) |
| PT (1) | PT2099796E (de) |
| TW (1) | TW200829586A (de) |
| WO (1) | WO2008067481A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2297070A2 (de) * | 2008-07-03 | 2011-03-23 | Bayer Schering Pharma Aktiengesellschaft | Verbindungen und verfahren zur herstellung von radiopharmazeutika |
| JP5651125B2 (ja) | 2008-12-10 | 2015-01-07 | デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド | Ｍｅｋ阻害剤に対する耐性を付与するｍｅｋ突然変異 |
| MX340392B (es) | 2010-02-25 | 2016-07-06 | Dana Farber Cancer Inst Inc | Mutaciones del protooncogen de serina/treonina-proteina cinasa b-raf (braf) que confieren resistencia a los inhibidores del protooncogen de serina/treonina-proteina cinasa b-raf. |
| BR112012022801B8 (pt) | 2010-03-09 | 2019-10-29 | Dana Farber Cancer Inst Inc | método de identificar um indivíduo que tem câncer que é provável beneficiar-se do tratamento com uma terapia de combinação com um inibidor de raf e um segundo inibidor e uso de um inibidor de raf e um segundo inibidor para a fabricação de um medicamento para tratar câncer |
| CA2806332C (en) | 2010-07-30 | 2017-11-14 | Oncotherapy Science, Inc. | Quinoline derivatives and melk inhibitors containing the same |
| US20150141470A1 (en) | 2012-05-08 | 2015-05-21 | The Broad Institute, Inc. | Diagnostic and treatment methods in patients having or at risk of developing resistance to cancer therapy |
| UY34893A (es) | 2012-07-10 | 2014-02-28 | Takeda Pharmaceutical | Derivados de azaindol |
| EP2916859B1 (de) | 2012-11-02 | 2017-06-28 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Verfahren zur reduktion von nebenwirkungen bei einem mit einem mek-hemmer behandelten krebspatienten |
| UA111925C2 (uk) | 2012-12-11 | 2016-06-24 | Федора Фармасьютікалз Інк. | БІЦИКЛІЧНІ СПОЛУКИ ТА ЇХ ВИКОРИСТАННЯ ЯК АНТИБАКТЕРІАЛЬНИХ АГЕНТІВ ТА ІНГІБІТОРІВ β-ЛАКТАМАЗИ |
| US9532987B2 (en) | 2013-09-05 | 2017-01-03 | Genentech, Inc. | Use of a combination of a MEK inhibitor and an ERK inhibitor for treatment of hyperproliferative diseases |
| MX2018012471A (es) | 2016-04-15 | 2019-02-21 | Genentech Inc | Metodos de diagnostico y terapeuticos para el cancer. |
| WO2018213810A1 (en) * | 2017-05-19 | 2018-11-22 | Nflection Therapeutics, Inc. | Pyrrolopyridine-aniline compounds for treatment of dermal disorders |
| CA3063535A1 (en) | 2017-05-19 | 2018-11-22 | Nflection Therapeutics, Inc. | Fused heteroaromatic-aniline compounds for treatment of dermal disorders |
| KR20200041387A (ko) | 2017-09-08 | 2020-04-21 | 에프. 호프만-라 로슈 아게 | 암의 진단 및 치료 방법 |
| WO2019158579A1 (en) | 2018-02-13 | 2019-08-22 | Vib Vzw | Targeting minimal residual disease in cancer with rxr antagonists |
| US11572344B2 (en) | 2018-11-20 | 2023-02-07 | Nflection Therapeutics, Inc. | Cyanoaryl-aniline compounds for treatment of dermal disorders |
| IL313821A (en) * | 2022-01-28 | 2024-08-01 | Insilico Medicine Ip Ltd | Ectonucleotide pyrophosphatase-phosphodiesterase 1 (ENPP1) inhibitors and their uses |
| WO2024033381A1 (en) | 2022-08-10 | 2024-02-15 | Vib Vzw | Inhibition of tcf4/itf2 in the treatment of cancer |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7235537B2 (en) * | 2002-03-13 | 2007-06-26 | Array Biopharma, Inc. | N3 alkylated benzimidazole derivatives as MEK inhibitors |
| JP4497930B2 (ja) * | 2002-04-23 | 2010-07-07 | アベンティス・ファーマスーティカルズ・インコーポレイテツド | インターロイキン−４遺伝子発現抑制剤としての３−置換アミノ−１Ｈ−インドール−２−カルボン酸および３−置換アミノ−ベンゾ（ｂ）チオフェン−２−カルボン酸誘導体 |
| US6929411B2 (en) * | 2003-09-03 | 2005-08-16 | Hewlett-Packard Development Company, L.P. | Selectable control of raster image processor |
| GB0412914D0 (en) * | 2004-06-10 | 2004-07-14 | Oxagen Ltd | Compounds |
| US7598259B2 (en) * | 2004-06-15 | 2009-10-06 | Schering Corporation | mGluR1 antagonists as therapeutic agents |
| AR049300A1 (es) * | 2004-06-15 | 2006-07-12 | Schering Corp | Compuestos triciclicos antagonistas de mglur1 como agentes terapeuticos |
| DE102005013621A1 (de) * | 2005-03-24 | 2006-09-28 | Curacyte Discovery Gmbh | Substituierte 2-Aryl(Hetaryl)-5-aminothieno[2,3-d]pyrimidin-6-carbonsäureamide, Verfahren zu ihrer Herstellung und Verwendung als Pharmazeutika |
| AR070127A1 (es) * | 2008-01-11 | 2010-03-17 | Novartis Ag | Pirrolo - pirimidinas y pirrolo -piridinas |
-
2007
- 2007-11-29 EP EP07854844A patent/EP2099796B1/de active Active
- 2007-11-29 WO PCT/US2007/085962 patent/WO2008067481A1/en active Application Filing
- 2007-11-29 CL CL200703444A patent/CL2007003444A1/es unknown
- 2007-11-29 CA CA002672327A patent/CA2672327A1/en not_active Abandoned
- 2007-11-29 DK DK07854844.3T patent/DK2099796T3/da active
- 2007-11-29 PT PT07854844T patent/PT2099796E/pt unknown
- 2007-11-29 AT AT07854844T patent/ATE511509T1/de active
- 2007-11-29 TW TW096145474A patent/TW200829586A/zh unknown
- 2007-11-29 PL PL07854844T patent/PL2099796T3/pl unknown
- 2007-11-29 JP JP2009539490A patent/JP5211063B2/ja not_active Expired - Fee Related
- 2007-11-29 PE PE2007001679A patent/PE20081354A1/es not_active Application Discontinuation
- 2007-11-29 US US11/947,656 patent/US7855216B2/en not_active Expired - Fee Related
- 2007-11-29 AU AU2007325123A patent/AU2007325123B2/en not_active Ceased
- 2007-11-29 AR ARP070105307A patent/AR064031A1/es unknown
-
2010
- 2010-03-12 HK HK10102582.8A patent/HK1135099A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010511626A (ja) | 2010-04-15 |
| WO2008067481A1 (en) | 2008-06-05 |
| AU2007325123B2 (en) | 2012-12-13 |
| EP2099796B1 (de) | 2011-06-01 |
| HK1135099A1 (en) | 2010-05-28 |
| PT2099796E (pt) | 2011-09-06 |
| JP5211063B2 (ja) | 2013-06-12 |
| US7855216B2 (en) | 2010-12-21 |
| TW200829586A (en) | 2008-07-16 |
| CA2672327A1 (en) | 2008-06-05 |
| DK2099796T3 (da) | 2011-09-05 |
| US20080242655A1 (en) | 2008-10-02 |
| PL2099796T3 (pl) | 2011-10-31 |
| AR064031A1 (es) | 2009-03-04 |
| EP2099796A1 (de) | 2009-09-16 |
| CL2007003444A1 (es) | 2008-06-27 |
| PE20081354A1 (es) | 2008-11-14 |
| AU2007325123A1 (en) | 2008-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE511509T1 (de) | Azaindolylverbindungen und anwendungsverfahren | |
| ATE531720T1 (de) | Aza-benzofuranylverbindungen und anwendungsverfahren dafür | |
| CY2019010I1 (el) | Νεες ενωσεις και συνθεσεις και μεθοδοι χρησης | |
| EP2023718A4 (de) | Kreatinligandverbindungen und anwendungsverfahren dafür | |
| DE602007013436D1 (de) | N-methylaminomethyl-isoindol-verbindungen und diese enthaltende zusammensetzungen und diese verwendende verfahren | |
| FI20065757A0 (fi) | Beta-laktamaasin käyttö | |
| DOP2010000044A (es) | Derivado de oxopirazina y herbicida | |
| DK1940839T3 (da) | Pyridopyrimidione Inhibitors of P13Ka | |
| DOP2007000084A (es) | Derivados de dihidropirazolopirimidinona | |
| IL198397A0 (en) | Anilinopiperazine derivatives and methods of use thereof | |
| DE602006007831D1 (de) | N-alkylcarbonylaminosäureester und n-alkylcarbonylaminosäurelaktonverbindungen und anwendung davon | |
| BRPI0906980A2 (pt) | Composição de derivados e maleatados | |
| IL194028A0 (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
| IL197060A0 (en) | Aza-benzothiophenyl compounds and methods of use | |
| DE602007010272D1 (de) | Parkhilfevorrichtung und parkhilfeverfahren | |
| CR10815A (es) | Nuevos derivados de isoquinolina e isoquinolinona sustituidos | |
| CR10562A (es) | Nuevos derivados de piridazina | |
| ATE526567T1 (de) | Zusammensteller und zusammenstellungsverfahren | |
| DK2034830T3 (da) | Anti-vla-1-antistof til behandling af slagtilfælde | |
| DK2069467T3 (da) | Adskillende sammensætninger og fremgangsmåder til anvendelse | |
| DK2001556T3 (da) | Thioninium-forbindelser og anvendelse deraf | |
| BRPI0918206A2 (pt) | derivados de animoéster e composição medicinal destes | |
| BRPI0713736A2 (pt) | Derivados de tetralina e indano e emprego destes | |
| ZA201000183B (en) | Quinazolinone compounds and methods of use thereof | |
| CR10809A (es) | Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 2099796 Country of ref document: EP |